STI Diagnostic Test Kits and Laboratory Suppliespdf icon (September 8, 2020)
- UPDATE (March 9, 2021)
Based on information from CDC-funded programs, public and private laboratories, and manufacturers, the availability of STI diagnostic testing supplies continues to improve. Some products have reportedly returned to normal levels while others remain at lower-than-normal levels. Manufacturers continue to report sustained efforts to expand the production and release of supplies in the coming months. In situations where STI testing supplies are not readily available, guidance on prioritizing testing in these circumstances can be found in the September 8, 2020 CDC Dear Colleague Letterpdf icon. In addition, laboratory providers and manufacturers can provide real-time information regarding local STI testing supplies levels. CDC’s Division of STD Prevention will continue to work with partners to address the availability of STI diagnostic testing supplies in the United States.
- UPDATE (November 24, 2020)
CDC DSTDP has received recent reports from CDC-funded STD programs, as well as public/private laboratories that some STI diagnostic testing supplies are becoming more readily available, but often at lower-than-normal order levels. DSTDP has also received reports from CDC-funded STD programs that are still experiencing some shortages of STI diagnostic testing supplies. Manufacturers are reporting ongoing efforts to increase production and release of product. However, the COVID-19 pandemic continues to impact the supply chain. A projected date for supplies to return to normal levels is unclear at this time. CDC’s Division of STD Prevention will continue to work with partners to address the availability of STI diagnostic testing supplies in the United States. In the interim, the CDC Dear Colleague Letter released on September 8, 2020 (above) provides guidance for prioritizing STI testing in the situation of diagnostic test shortages.